The Deal
Sunday, November 8, 
4:38 am

Sevin Rosen's Jon Bayless on early-stage investing

  Share     E-Mail    Discussion    Print Story

Jon_Bayless_Sevin_Rosen.jpgSpeaking at the Argyle Executive Forum's 2007 Leadership in Venture Capital Conference, investment veteran Jon Bayless, a general partner at Sevin Rosen Funds, spoke about the changing state of the venture capital industry.

Citing statistics, he said that the valuations of startups are still at historically high levels; moreover, the valuations that portfolio companies are getting in middle- and late-stage rounds are trending upwards, which is a good sign for early-stage investors like Sevin Rosen.

Continue reading below

Also on Dealscape

He also spoke on the importance of figuring out early if a portfolio company is building a company or just a product, and letting the entrepreneur know from Day 1 what to expect the exit to be: a trade sale or an IPO. While venture capitalists prefer to be in the business of building standalone enterprises, a company building a product in hopes of a buyout has the benefits of needing less money in the middle rounds since it won't have to build out a big infrastructure such as a large sales team.

As for the public markets, Bayless expects the IPO window will remain open, but added that the time span required to bring a company to the point where it can go public has widened to around 8 years; leading to a corresponding increase in the amount of capital venture firms must invest in a company over the life of the relationship. The longer time span is creating problems for some VC firms which are working on a 10-year life cycle for their investment funds. Sevin Rosen is combating the changing environment by diversifying the industries in which it invests. After more than 25 years of backing only  information technology and communications startups, the firm's ninth fund now includes life sciences companies, as well as energy and materials companies.

However, Sevin Rosen remains dedicated to its core strategy of investing in seed- and early-stage startups. Bayless said that in its ninth fund, over 50% of the portfolio companies were backed at the seed/incubation level, and another 25% were initially backed at the first round. —George White

 





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.